These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568 [TBL] [Abstract][Full Text] [Related]
10. Statins and myositis: the role of anti-HMGCR antibodies. Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593 [TBL] [Abstract][Full Text] [Related]
11. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies]. Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872 [TBL] [Abstract][Full Text] [Related]
12. Spectrum of immune-mediated necrotizing myopathies and their treatments. Pinal-Fernandez I; Mammen AL Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340 [TBL] [Abstract][Full Text] [Related]